Key takeaways for California
- • FDA labels require BMI 30+ or 27+ with comorbidity for approved weight-loss GLP-1s.
- • Mean weight loss: roughly 15% with semaglutide, roughly 21% with tirzepatide at one year.
- • Weight regain is common after stopping — most clinicians frame this as chronic therapy.
- • Medi-Cal coverage rules apply for Obesity / Chronic Weight Management patients in California — see Medicaid section below.
- • 16 GLP-1 telehealth providers available nationwide.
Why GLP-1 medications for Obesity / Chronic Weight Management
Wegovy (semaglutide 2.4 mg) and Zepbound (tirzepatide) are FDA-approved specifically for chronic weight management in adults with obesity, or overweight with at least one weight-related condition. Evidence grade: A. STEP and SURMOUNT trial programs established mean total body weight loss of approximately 15% with semaglutide 2.4 mg and approximately 21% with tirzepatide 15 mg at 72 weeks. Saxenda (liraglutide 3.0 mg) is also approved but less effective. Weight regain is common after discontinuation, so most experts treat obesity as chronic and indefinite, similar to hypertension.
California-specific context
California has telehealth access concentrated in Los Angeles, San Diego, San Jose metros, with additional reach to San Francisco and Fresno. Kaiser Permanente, UCSF, Stanford Health, UCLA Health, Cedars-Sinai is the largest in-state academic medical center for endocrine + obesity-medicine specialty consults. The state health authority publishes prescribing + coverage updates at www.cdph.ca.gov.
Californiatelehealth & pricing rules
- • California requires a live video consultation before a GLP-1 prescription.
- • California allows new-patient telehealth prescribing without a prior in-person visit.
- • Typical cash GLP-1 price in California: ~$285/mo (compounded options often lower, brand higher).
State telehealth statutes change — verify current rules with your provider before booking.
FDA-approved GLP-1 medications for Obesity / Chronic Weight Management
- Saxenda (liraglutide) — FDA-approved for Obesity / Chronic Weight Management
- Wegovy (semaglutide) — FDA-approved for Obesity / Chronic Weight Management
- Compounded Semaglutide (semaglutide (compounded)) — off-label or related; consult prescriber
- Zepbound (tirzepatide) — FDA-approved for Obesity / Chronic Weight Management
- Compounded Tirzepatide (tirzepatide (compounded)) — off-label or related; consult prescriber
Telehealth providers licensed in California
Top GLP-1 providers for Obesity / Chronic Weight Management in California
SponsoredPartner offers first — we earn a commission from those — then ranked by our editorial score. Visit a partner to check current pricing and eligibility.
Advertising disclosure: we may earn a commission if you sign up through these links, at no extra cost to you. Partner offers are listed first; payment never changes a score. How we make money
- Sesame Care· from $208/moNo lab work to startTelehealth · California residents
- SkinnyRx· from $199/moCompounded not offered in AL, LA, MS — check before startingTelehealth · California residentsCompounded · not FDA-approved
- Enhance MD· price shown after their intakeRestricted in AL, AR, GA, HI, LA, MS, MO, ND, SC, TN, WV — check before startingTelehealth · California residentsCompounded · not FDA-approved
- HealthRX· from $165/moLowest starting pricemonthly Subscribe & Save ($149 first month); $99/mo on the 12-month plan, $1,188 upfrontTelehealth · California residentsCompounded · not FDA-approved
These 16 GLP-1 telehealth providers operate nationally — confirm California availability with each. Always verify current state availability with the provider directly before paying.
- RoHealthcare on your terms — including FDA-approved weight loss.
- HersFDA-approved weight loss treatments with personalized care.
- HimsMen's health telehealth — including GLP-1 weight loss.
- Sesame Care
- LifeMDTelehealth with FDA-approved GLP-1 medications.
- PlushCareBoard-certified physicians, FDA-approved GLP-1 access.
- Mochi HealthDoctor-led weight care, accessible and personal.
- WeightWatchers ClinicWW + Sequence telehealth: behavior + GLP-1 combined.
- FoundPersonalized weight care with prescription medication.
- CalibrateYear-long metabolic reset with GLP-1 and coaching.
Medi-Cal coverage notes
Diabetes indication only
California Medicaid covers GLP-1s for type 2 diabetes but not for weight loss on its own, so a prescription written for obesity alone is generally denied. Prior authorisation applies to the diabetes indication too. Coverage reflects KFF's Medicaid GLP-1 tracker as of January 2026, checked 2026-08-20; state formularies change mid-year, so confirm with your plan before you rely on it.
Medicaid coverage for GLP-1 medications varies state-by-state. Federal statute (Medicare Part D, MMA 2003 / SSA §1860D-2(e)(2)(A)) excludes weight-loss drugs from Medicare — state Medicaid programs may follow or expand coverage. Medi-Cal coverage rules and prior-authorization criteria are published by the state Medicaid agency — see our California Medicaid GLP-1 guide for the current detail.
Evidence supporting GLP-1 use for Obesity / Chronic Weight Management
- STEP 1 (2021, NEJM): semaglutide 2.4 mg achieved 14.9% weight loss vs 2.4% placebo over 68 weeks.
- SURMOUNT-1 (2022, NEJM): tirzepatide 15 mg produced 20.9% weight loss vs 3.1% placebo over 72 weeks.
- STEP 5 (2022): weight loss maintained out to 104 weeks on continued semaglutide therapy.
- STEP 4 (2021): withdrawal led to regain of approximately two-thirds of lost weight within one year.
Obesity / Chronic Weight Management in California — FAQ
Does California Medicaid cover GLP-1 medications for Obesity / Chronic Weight Management?
California Medicaid covers GLP-1s for type 2 diabetes but not for weight loss on its own, so a prescription written for obesity alone is generally denied. Prior authorisation applies to the diabetes indication too. Coverage reflects KFF's Medicaid GLP-1 tracker as of January 2026, checked 2026-08-20; state formularies change mid-year, so confirm with your plan before you rely on it. Coverage for Obesity / Chronic Weight Management specifically depends on your plan, diagnosis, and prior-authorization criteria.
Can I get GLP-1 treatment for Obesity / Chronic Weight Management through telehealth in California?
Yes — telehealth providers serving California can prescribe GLP-1 medications for Obesity / Chronic Weight Management when clinically appropriate. California requires a live video consultation before a GLP-1 prescription. Always work with a licensed prescriber; GLP1Zoom compares options but does not prescribe.
Which GLP-1 medications are used for Obesity / Chronic Weight Management?
Wegovy (semaglutide 2.4 mg) and Zepbound (tirzepatide) are FDA-approved specifically for chronic weight management in adults with obesity, or overweight with at least one weight-related condition. Evidence grade: A. STEP and SURMOUNT trial programs established mean total body weight loss of approximately 15% with se…
Next steps for California patients
- Review FDA-approved GLP-1 options for Obesity / Chronic Weight Managementabove; bookmark the drug pages that match your prescriber's preferences.
- Check your insurance coverage via our payer lookup tool — Medi-Cal rules differ from commercial plans.
- Match with a telehealth provider licensed in California — our 60-second quiz filters by state, indication, and cost preference.
- Bring this page plus a current medication list to your prescriber appointment.
Obesity / Chronic Weight Management treatment requires individualized medical assessment. GLP1Zoom is an affiliate-only comparator and does not prescribe medications. State-specific coverage and telehealth rules change; always verify with your prescriber and insurer before acting. Full disclaimer.